Celanese Presents EVA Polymer Solutions for Drug Delivery Systems at CPhI Worldwide
By Business Wire News
By Business Wire News
DALLAS & MADRID
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present innovative uses of ethylene vinyl acetate (EVA) at the 2015 CPhI Worldwide conference October 13-15 in Madrid, Spain. Celanese material experts will exhibit the innovative controlled release pharmaceutical copolymer, VitalDose® EVA, at booth number 7A54SSP in Hall 7.
“EVA has been used for years in drug delivery systems,” said Dr. Donald Loveday, Celanese strategic marketing manager. “VitalDose EVA is an inert thermoplastic that is expanding design possibilities with its customizable drug release properties. This controlled release excipient is developed for a wide variety of pharmaceutical products with varying routes of administration, including intraoral, intravaginal, ocular, subcutaneous and transdermal.”
Celanese material experts will discuss these topics and more at a Pharma Insight Briefing & Reception:
- Why use EVA in Drug Development and Controlled Release
- Current Application Areas and Uses of EVA
- Next Generation Innovations for EVA
- Celanese Support of Conventional and Novel Uses of EVA
Celanese Pharma Insight Briefing & Reception
Tuesday, October 13, 2015 at 16:00
|Location:||Pharma Forum, 2015 CPhI Worldwide|
|Presenters:||Dr. Donald Loveday, Strategic Marketing Manager and Dr. Christian Schneider, Technical Service and Product Developer|
Innovative Uses of Ethylene Vinyl Acetate (EVA) in Drug Delivery Systems: Novel and Conventional
For more information about Celanese’s controlled release pharmaceutical EVA polymer, VitalDose EVA, visit www.vitaldose.com.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,500 employees worldwide and had 2014 net sales of $6.8 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International Corporation or its affiliates.
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or any of its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Jon Puckett, +1-972-443-4965
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574